Magnesium genuinely lowers blood pressure by a couple of points in pooled trials and shows modest sleep benefits in the sleepless — but most of the research used other salt forms, so the glycinate-on-your-nightstand's specific claims run ahead of the evidence.

So somewhere along the way — and if you've been anywhere near a wellness podcast or the supplements end of the internet you know exactly when this happened, which is gradually and then all at once — magnesium became the mineral, the one everyone is suddenly taking before bed, the one that gets recommended for sleep and stress and muscles and mood with the kind of serene confidence usually reserved for things like gravity, and the specific form on every nightstand is magnesium glycinate, the glycine-chelated one, because glycine itself is sort of sleep-adjacent and so the whole package just feels right, pharmacologically speaking, even if almost nobody can tell you what the trials actually showed or — and this turns out to matter — which form of magnesium the trials even used.
Here is what magnesium actually is: an essential mineral, the second most abundant intracellular cation, cofactor in more than 300 enzymatic reactions, involved in energy metabolism, nerve and muscle function, vascular tone. Intakes below recommended amounts are common. None of that is hype; all of it is textbook.
The question is what supplementing it fixes. The most defensible answer: blood pressure a little, sleep a little, migraine plausibly — with the largest benefits in people who actually need them, and with a form-of-magnesium caveat the marketing never mentions.
The best-pooled number comes from a meta-analysis of 34 randomized trials in Hypertension: oral magnesium lowered blood pressure by about 2 mmHg. A 2025 systematic review and meta-analysis in the same journal revisited the question, and a 2020 meta-analysis in Biological Trace Element Research examined type 2 diabetes patients specifically. The pattern across all of them: larger reductions in people who are hypertensive, magnesium-deficient or insulin-resistant — and generally no significant effect in people with normal blood pressure. Two points of pressure is not nothing at population scale, but it is not a reason for a normotensive person to expect anything measurable.
The sleep claim has more trial support than most nightstand supplements can claim, with a characteristic twist. A placebo-controlled trial in elderly people with primary insomnia found magnesium improved sleep scores and efficiency while raising melatonin and lowering cortisol. A 2025 trial tested magnesium bisglycinate itself — the actual form being sold for sleep — and found modest improvement in insomnia severity among adults reporting poor sleep, especially those with low dietary magnesium intake. Notice the throughline: benefit tracks with deficiency. The molecule seems to fill a hole better than it raises a ceiling.
A 2018 systematic review in Headache asked whether there's an evidence-based rationale for magnesium in migraine prophylaxis, and a 2016 meta-analysis in Pain Physician pooled trials of intravenous and oral magnesium for reducing migraine — enough that headache specialists genuinely consider it. Meanwhile, prospective cohorts link higher dietary magnesium intake to lower risks of type 2 diabetes, coronary heart disease and all-cause mortality. Cohort findings, though: association, not causation. People who eat magnesium-rich whole grains, legumes, nuts and greens do a lot of other things too.
Which brings us to the quietest, most important fact in this piece: most of the trials behind every claim above used magnesium oxide, citrate or other salts — not glycinate. The 2025 bisglycinate sleep trial is the exception that proves the rule. Claims that the glycinate form is superior outrun the evidence; it is a reasonable way to take magnesium, not a proven better one. And all of this evidence describes the mineral, not any specific commercial product.
So the nightstand ritual is neither silly nor sacred. If your diet is thin on greens and grains, a supplement is a defensible patch; if it isn't, the capsule is mostly an expensive lullaby — which, to be fair, is roughly what the trials of the well-nourished found too. Educational, not medical advice.
Oral magnesium lowers blood pressure about 2 mmHg on average and can modestly improve insomnia, especially in people with low intake — but benefits are small, absent in the already-healthy, and mostly not specific to the glycinate form.
5 peer-reviewed sources, published 2016–2025, across 4 journals. 3 of them have a full Magellan study write-up linked below.
Each links to its Magellan monograph — what it is, what it does, and the studies behind it.
The giant COSMOS trial gave cocoa flavanols the fairest test any supplement has had. The headline outcome…
Glycine is a building block for collagen, glutathione, creatine and heme, and small trials show 3 grams…
Animal work suggests brain penetration, but human cognition trials are small, often use combination…
All Magellan articles → · More on Nutraceuticals & Cellular Energizers →
Prefer the interactive version? Open this article inside the Magellan app →